Jan 8 (Reuters) – If you went to visit your doctor and a drug company representative was sitting in the room with you, ready to hand out pamphlets and samples, you’d likely cry foul.

Depending on what electronic health record system your physician uses, the digital version of this sort of thing is already happening.

New regulations in the Affordable Care Act restrict access to doctors by pharmaceutical companies. As a result, drug companies are finding their way behind the medical industry’s closed doors via digital record-keeping systems.

These systems are able to crunch a lot of health information and spit out reports, stripped of data identifying specific patients, that the pharmaceutical industry finds useful. The process is not altogether shocking

Click Here To Read More